You may soon be able to eat your Ozempic… sort of. GLP-1 supplements are booming, promising to deliver similar benefits to ...

A rise in the use of non-FDA-approved diabetes and obesity medications has spurred health care professionals and medical ...

G lucagon-like peptide-1 receptor agonists, aka GLP-1 agonists, such as semaglutide -- better known as Ozempic -- have ...

FDA ends GLP-1 drug shortage. Concerns over safety, counterfeit drugs, and high cost of brand-name versions persist; ...

The once-daily pill combines Opko’s long-acting GLP-1/glucagon dual agonist peptide, dubbed OPK-88006, with Entera’s N-Tab ...

The exorbitant costs of drugs like Wegovy — especially compared to other countries — have prompted some insurers to tighten ...

GLP-1 medications, such as Ozempic, reduce cravings. Andy Wardlaw of MMR Research says marketers must now work harder to ...

The cost gap is what makes GLP-1 compounding such a unique situation. Usually drugs that go into shortage are cheap generics, not expensive brand-name ones that are still under patent, Tenille ...

GLP-1 medications like Ozempic are reshaping the way people snack, with fewer ultra-processed foods and a shift toward nutrient-packed bites. See what’s in and what’s out.

A few generic and brand names of GLP-1 agonists, according to the Johns Hopkins Patient Guide to Diabetes, include: Each brand has its own recommended dosage and frequency of intake. Some may be ...